Last update 14 Jan 2026

GeGant

Overview

Basic Info

Drug Type
Diagnostic radiopharmaceuticals
Synonyms
Gallium (68Ga) chloride/Germanium (68Ge) chloride, EZR001, GalliaPharm
+ [4]
Target-
Action
enhancers
Mechanism
Radionuclide imaging enhancers
Therapeutic Areas
Other Diseases
Active Indication
Diagnostic agentsContrast agents
Inactive Indication-
Originator Organization
ITM Medical Isotopes GmbH
Active Organization
Eckert & Ziegler Radiopharma GmbHCurium Holding France SASUCurium Holding France SASUIre EliT NV
+ [1]
Inactive Organization
ITM Medical Isotopes GmbH
License Organization-
Drug Highest PhaseApproved
First Approval Date
Canada (13 Nov 2019),
Contrast agents
Regulation-
Login to view timeline

Related

5
Clinical Trials associated with GeGant
CTIS2024-517270-23-00
/ Not yet recruitingPhase 2IIT
"Diagnostic value of 68Ga-FAPI-46 PET/CT in the initial work-up of pancreatic and biliary cancers eligible to a curative treatment" "FAPDIG"
CTIS2025-521682-27-00
/ SuspendedPhase 4IIT
Sentinel lymph node (SLN) detection in early oral cancer using Gallium-68-Tilmanocept PET/CT.
CTIS2023-506594-35-00
/ RecruitingPhase 4
[68Ga]Ga-FAPI-46 positron emission tomography for detection of lymph node metastasis in early rectal cancer (FARE Trial)
100 Clinical Results associated with GeGant
Login to view more data
100 Translational Medicine associated with GeGant
Login to view more data
100 Patents (Medical) associated with GeGant
Login to view more data
100 Deals associated with GeGant
Login to view more data

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Diagnostic agents
European Union
Curium Holding France SASUCurium Holding France SASU
08 Jan 2026
Diagnostic agents
Iceland
Curium Holding France SASUCurium Holding France SASU
08 Jan 2026
Diagnostic agents
Liechtenstein
Curium Holding France SASUCurium Holding France SASU
08 Jan 2026
Diagnostic agents
Norway
Curium Holding France SASUCurium Holding France SASU
08 Jan 2026
Contrast agents
Canada
Ire EliT NV
13 Nov 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free